|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.40 USD | -2.36% |
|
+0.45% | +6.74% |
| 06-18 | Barclays Initiates Indivior at Overweight With $46 Price Target | MT |
| 06-10 | Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.36% | +0.45% | +4.82% | +25.45% | +6.74% | +175.54% | +68.87% | +248.18% | +143.95% | 4.67B | |
| +32.62% | -5.37% | +11.18% | +19.66% | +2.22% | +39.94% | +145.38% | +402.66% | +1,387.37% | 980B | |
| -3.20% | -4.17% | -0.23% | -3.75% | +10.36% | +51.52% | +39.07% | +41.00% | +97.77% | 550B | |
| -2.14% | -3.68% | +3.38% | +3.91% | -5.25% | +16.71% | +56.15% | +91.38% | +260.76% | 382B | |
| -2.13% | +0.25% | +1.37% | +3.59% | -0.64% | +25.86% | +16.53% | -6.36% | +35.65% | 317B | |
| +0.40% | -2.04% | -4.99% | -6.55% | -4.37% | +24.98% | +13.24% | +56.85% | +242.72% | 270B | |
| +0.59% | -2.93% | -0.45% | +1.39% | +8.12% | +24.46% | +30.43% | +37.53% | +56.02% | 269B | |
| +4.64% | +2.05% | +1.97% | +23.22% | -9.87% | -39.98% | -45.85% | +13.56% | +71.94% | 191B | |
| -1.90% | -4.65% | +4.07% | -3.95% | +3.14% | +16.56% | +47.00% | +41.44% | +125.64% | 182B | |
| -1.35% | -1.68% | -4.56% | -12.41% | +0.83% | +14.59% | +56.94% | +85.80% | +49.74% | 154B | |
| 0.00% | -3.67% | -0.47% | -7.72% | +1.24% | +5.57% | -37.07% | -35.04% | -26.33% | 144B | |
| -1.60% | +1.48% | +3.45% | +0.01% | -0.38% | +0.72% | +29.82% | +140.42% | +420.73% | 115B | |
| -1.93% | -5.10% | -5.78% | -9.04% | +0.11% | +15.29% | -18.38% | -18.76% | -23.59% | 110B | |
| +0.36% | -2.80% | +1.39% | -1.41% | +5.70% | +34.39% | +42.66% | +9.03% | +8.88% | 102B | |
| -0.05% | -4.37% | -2.61% | -6.28% | -11.46% | -11.89% | -22.49% | -16.98% | +5.38% | 101B | |
| -0.21% | +1.34% | -4.86% | -12.72% | -8.41% | +4.73% | +78.19% | +83.21% | +538.93% | 77.35B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -2.04% | -2.91% | -6.11% | -14.46% | +2.05% | +14.80% | +6.45% | +34.92% | +11.00% | 49.43B | |
| +3.04% | +3.07% | -7.65% | -14.87% | -18.72% | -6.54% | +1.94% | -32.22% | +231.79% | 47.38B | |
| +0.38% | +3.29% | -2.96% | -2.82% | +1.00% | +38.80% | -27.59% | -28.38% | -58.66% | 41.89B | |
| Average | -0.32% | -1.48% | -0.48% | -0.99% | -0.92% | +23.48% | +25.33% | +60.43% | +188.40% | 207.48B | |
| Weighted average by Cap. | -0.89% | -2.95% | +2.43% | +3.66% | +0.90% | +24.74% | +52.55% | +125.68% | +426.70% |
- Stock Market
- Stocks
- INDV Stock
- Sector Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
